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the OAT group (p<0.05). MRI evaluation after 5 years demon-
strated excellent or good repairs in 94% after OAT compared
with 52% after MF. Twenty-six (93%) athletes following OAT and
fifteen (52%) athletes following MF returned to sports activities
at the pre-injury level at an average of 9.5 months (range 7
to 11 months) after the operations. Twenty-four (86%) athletes
following OAT and fifteen (35%) athletes following MF continue
to sports activities at the pre-injury level at an average of 5.4
years after the operations. Others showed a decline in the sport
activity level.
Conclusions: At an average of 5 years (range from 4 to 7
years) follow-up, our prospective, randomized, clinical study in
young active athletes under the age of 40 has shown significant
superiority of the OAT over microfracture for the repair of artic-
ular cartilage defects in the knee. Regarding return to sports,
we found that only 35% of MF athletes could continue sports
activities at the preinjury level.
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COMP MUTATIONS AFFECT EXPRESSION PATTERNS OF
EXTRACELLULAR MATRIX PROTEINS DURING IN VITRO
CHONDROGENESIS
J.A. Roman-Blas, R.M. Seghatoleslami, A.S. Dion, K. Giunta,
P. Oca, F. Han, S.A. Jimenez, C.J. Williams
Thomas Jefferson University, Philadelphia, PA
Purpose: Mutations in human cartilage oligomeric matrix protein
(COMP) cause two skeletal dysplasias: pseudoachondroplasia
(PSACH) and multiple epiphyseal dysplasia (MED). We studied
the effects of over-expression of wild type (wt) COMP and ex-
pression of mutant COMP on early stages of chondrogenesis in
chicken limb bud micromass cultures.
Methods: RCAS virus with wt or mutant (C328R, PSACH;
T585R, MED) chick COMP cDNA inserts were transfected into
chicken limb bud cells and cells were plated as micromass cul-
tures. Cells were harvested at days 3, 4 and 5. The extent
of chondrogenesis was assessed by real time PCR analysis
of COMP, col2a1, col9a1, matrilin 3 (mat 3), syndecan 3, and
tenascin C mRNA expression. Alcian blue staining of the cul-
tures, 35S sulfate incorporation, and western blots reacted with
antibodies to COMP, type II collagen, and mat 3 were also per-
formed. Cell proliferation was estimated by WST-1 assay, and
real time PCR measurements of p21 and p27 mRNA levels were
assayed.
Results: The expression of wt or mutant COMP proteins was
confirmed in all transfected cells. Compared to untransfected
control, cells transfected with wt COMP showed a statistically
significant increase of type IX collagen mRNA at days 4 and 5 of
harvest. Indicative of sulfated proteoglycan synthesis, alcian blue
staining, 35S sulfate labeling, and expression of aggrecan and
syndecan were higher in cells over-expressing wt COMP, partic-
ularly at day 5 of harvest, than untransfected control cells. The
expression of type II collagen and mat 3 were not significantly
different in the COMP over-expressing cells than control cells at
all days of harvest. In contrast to cells over-expressing wt COMP,
cultures transfected with COMP mutants showed significant de-
creases in type IX collagen expression at all days of harvest.
Furthermore, in the T585R mutant, alcian blue staining intensity,
as well as 35S sulfate incorporation and expression of aggrecan
and syndecan 3, were decreased at day 3 of harvest. However,
in the T585R mutant, alcian blue staining intensity recovered at
later harvest times, suggesting increased accumulation of sul-
fated proteoglycan that may relate to decreased protein turnover.
Interestingly, and in contrast to cells over-expressing wt COMP,
the mRNA and protein expression of mat 3 in the mutants was
significantly increased at day 3 of harvest; however at later days,
protein expression of mat 3 was decreased in the mutants. Sig-
nificant reduction of WST-1 activity, and p21 and p27 mRNA
levels were observed in cultures that over-expressed COMP or
expressed mutant COMP.
Conclusions: COMP mutations cause a significant decrease
of type IX collagen at all three days of harvest. Conversely,
over-expression of wild type COMP causes a significant increase
in type IX collagen expression. Expression of mat 3 was not
significantly different from control cells in cells over-expressing
wild type COMP, but was higher in mutants at day 3 of harvest.
Interactions between COMP and other components of the extra-
cellular matrix of cartilage, including type IX collagen and mat 3,
occur during early stages of chondrogenesis. Our studies sug-
gest that COMP mutations disrupt these normal interactions and
also influence rates of proliferation of chick limb bud micromass
cultures during chondrogenesis.
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Radboud University Medical Center Nijmegen, Nijmegen, The
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Purpose: There has been a huge interest in the involvement of
Toll-Like Receptors (TLR) in human and experimental arthritis.
Several endogenous ligands for TLR, like biglycan, are present in
osteoarthritic joints. However, the involvement of these receptors
in osteoarthritis (OA) has not been studied extensively. The
present study was performed to evaluate the role of TLR-2 and
TLR-4 in experimental OA pathology.
Methods: Experimental OA was induced by 2 intra-articular
injections of 1 Unit collagenase into murine knee joints. Due to
the instability that results from these injections, OA-like pathology
develops within 42 days. At day 42, knee joints are dissected and
processed for histological examination. OA-like changes in the
cartilage of 4 joint surfaces were scored using a gradual scale
from 0-5. Five sections of each joint were scored, resulting in a
maximum score of 30 of each surface. The role of TLR2 was
studied by induction of experimental OA in TLR2-/- mice (n=16)
and C57BL/6 controls (n=15), and the involvement of TLR4 was
studied in C3H/Hej mice and their C3H/Hen controls (n=15 in
both groups). C3H/Hej are LPS insensitive mice because of a
point mutation in the gene coding for TLR4, which leads to TLR4
dysfunction.
Results: In control joints of all murine strains, no spontaneous
OA lesions were observed. After induction of OA, mild os-
teoarthritic lesions developed in knee joints of C3H/Hen mice,
with a mean score of 8,2. Surprisingly, in stead of suppressed
OA, C3H/Hej mice showed markedly increased overall OA pathol-
ogy in the cartilage, with a score of 13,3 (p<0,02). The largest
effect of TLR4 absence was in the tibial plateau, both in the
lateral (p<0,01) and in the medial (p<0,001) compartment, with
OA score increasing with respectively 40% and 370%. Incidence
of severe OA pathology, deep fissures to complete erosion in at
least 1 surface, was increased from 13% in C3H/Hen to 43% in
the TLR4 deficient C3H/Hej mice.
In TLR2-/- mice, OA pathology increased from 10,0 in the wild-
type controls to 15,5 (p<0,02). Changes were observed in all
surfaces, but were strongest in the lateral compartment of the
joint, both in the femur and tibia. Incidence of severe cartilage
damage was increased in the medial femur, medial tibia, lateral
femur and lateral tibia respectively from 13% to 44%, from 27%
to 69%, from 60% to 81% and from 53% to 81%. For TLR2, these
observations were in line with the findings in an inflammatory
model for rheumatoid arthritis, which is based on the occur-
rence of spontaneous arthritis in IL-1ra deficient conditions. In
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this arthritis model inflammation was increased in TLR2-/- mice.
In contrast, inflammation in TLR4-/- mice was decreased in the
arthritis model. However, in experimental OA in all strains, no
obvious differences in inflammation were found, so mechanisms
of action of TLR deficiencies in OA are probably unrelated to
inflammation.
Conclusions: In contrast to our expectations, these studies
indicate that both in TLR2 and TLR4 deficient mice OA pathology
is more severe when experimental OA is induced. This suggest
protective roles for both receptors in OA, in stead of the inducing
roles that were anticipated. The mechanisms via which TLR2 and
4 exert this effect remain unclear, although stimulation of TLR2
and 4 by endogenous ligands such as biglycan has been shown
to induce IL-10, TGFβ and HGF, which are protective mediators
for OA. The differences in preference for the joint compartment
may indicate different mechanisms, or differences in TLR2 and
4 distribution in the cartilage, but may also reflect strain related
differences. Although further research is needed, these results
indicate that during OA certain TLR pathways protect cartilage
from developing OA which may lead to clues for future therapy.
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NOVEL FUNCTIONS OF THE TIA-1 ARTHRITIS
SUPPRESSOR PROTEIN IN REGULATING TYPE II
PROCOLLAGEN GENE EXPRESSION
A. McAlinden, L. Liang, Y. Mukudai, T. Imamura, L.J. Sandell
Washington University, St Louis, MO
Purpose: One of the most important alternative splicing events
identified in connective tissue biology is the developmentally-
regulated processing of COL2A1. Here, exon 2, encoding a
cysteine-rich domain in the N-propeptide, is included in or ex-
cluded from mature mRNA producing type IIA (+ exon 2 in
chondroprogenitor cells) or type IIB procollagen (-exon 2 in dif-
ferentiated chondrocytes) (Fig.1A). We recently identified a novel
cis element in intron 2 of COL2A1 (Fig.1B) and proceeded to
investigate what trans-acting factors bind to this U-rich region.
We chose the arthritis suppressor RNA binding protein, TIA-1
(T-cell intracellular antigen 1), as a potential candidate as it has
been shown to regulate alternative splicing of other genes by
interacting with U-rich intronic sequences.
Methods: A COL2A1 mini-gene (Fig.1A) was co-transfected with
a TIA-1-encoding cDNA construct into different chondrocyte and
non-chondrocyte cells. RT-PCR of harvested mRNA was done
using primers specific for the COL2A1 mini-gene (Fig. 1A). IIA
and IIB cDNA isoforms were analyzed by phosphor-imaging.
TIA-1 was co-transfected with COL2A1 mini-genes containing
mutations in the T/U-rich region. Endogenous TIA-1 mRNA or
protein was analyzed by RT-PCR or Western blotting of nuclear
extracts. A GST/TIA-1 fusion protein was synthesized and used
in binding assays with radio-labelled RNA or DNA probes cor-
responding to the T/U-rich 38 nucleotide cis element (Fig.1B).
Electromobility shift or UV cross-linking assays were done to
detect protein/probe complexes in the presence or absence of
various competitors. Chromatin or RNA immunoprecipitation as-
says were done to confirm in vivo interaction of genomic DNA or
pre-mRNA with endogenous TIA-1 protein in the nucleus.
Results: TIA-1 regulated alternative splicing by increasing the
IIA mRNA isoform (+exon 2) in human chondrocytes and non-
chondrocytes. These cells also contained the highest levels of
endogenous TIA-1 compared to other cell types analyzed. Co-
transfection of TIA-1 with mutant COL2A1 mini-genes suggested
that the U-rich stretch (AUUUAUUUAUUU) was a potential TIA-1
RNA binding site. This was confirmed by RNA/protein binding
assays. GST/TIA-1 fusion protein interacted with the wild-type
RNA probe, but not with a mutant probe containing nucleotide
substitutions in the U-rich region. Interestingly, TIA-1 was found
to bind to the equivalent DNA T-rich probe, with a preference
for single-stranded rather than double-stranded DNA. The DNA
probe bound to TIA-1 with higher affinity than RNA yet, in
both cases, the major TIA-1 binding site was in the T/U-rich
region. Immunoprecipitation assays confirmed in vivo binding of
endogenous TIA-1 to COL2A1 genomic DNA and pre-mRNA.
Conclusions: This is the first report indicating TIA-1 as a reg-
ulator of COL2A1 alternative splicing. We also report a novel
function for TIA-1 by its ability to bind genomic DNA as well as
RNA. We suggest TIA-1 has a dual role in regulating COL2A1
expression by functioning at the level of transcription and pre-
mRNA splicing. TIA-1 is known to down-regulate expression
of the inflammatory mediators TNF-α and COX-2 by binding
adenylate/uridylate rich elements (AREs) in the 3’ untranslated
region of mRNA. These AREs contain repeats of the AUUUA
pentameric sequence also found in the COL2A1 cis element de-
scribed here. Since expression of the embryonic type IIA isoform
has been detected in osteoarthritic cartilage, TIA-1 may function
in promoting a tissue repair response by altering expression of
specific cartilage matrix protein isoforms in addition to repressing
inflammatory cytokine expression.
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F-SPONDIN, A NEURONAL DIFFERENTIATION FACTOR,
IS UPREGULATED IN OSTEOARTHRITIS: EVIDENCE FOR
REGULATION OF CHONDROCYTE METABOLISM VIA
LATENT TGF-B1 ACTIVATION
M. Attur, G. Palmer, H. Al-Mussawir, D. Rifkin, C. Teixeira,
F. Beier, S.B. Abramson
NYU Hospital for Joint Diseases, New York, NY
Purpose: F-spondin, first identified as a novel protein secreted
by neuronal cells, is a member of a family of proteins that collec-
tively belong to a subgroup of TSR (thrombospondin) type I class
molecules. We have discovered, using Affymetrix microarray
screening followed by confirmatory immunoblot and immunohis-
tochemistry, that F- spondin expression is significantly increased
in osteoarthritic cartilage. We here report studies designed to
elucidate its role.
Methods: Gene expression studies of cartilage from normal and
OA patients were performed using Affymetrix U95Av2 microarray.
The microarray data was normalized and analyzed using dchip
program. The differentially expressed gene was confirmed using
TaqMan Real Time PCR. Chondrocytes were isolated from OA
patients undergoing joint replacement surgery, using collagenase
digestion and cultured in monolayer. Prostaglandin E2 (PGE2),
was estimated using radioimmunoassay. The active and total
TGF-b1 was estimated using R&D systems ELISA kits.
Results: We studied the expression of F-spondin in 18 OA and
8 age-matched normal cartilage and synovium using Affymetrix
microarray. The OA specimens were obtained at the time of
joint replacement surgery and the normal tissues from acci-
dent victims. F-spondin was overexpressed in OA chondrocytes
(2-5 fold). The differential expression of F-spondin in cartilage
was confirmed by real time PCR and western blot. The expres-
sion of F-spondin in OA cartilage was also confirmed by im-
munostaining. F-spondin mRNA expression was also increased
in rat meniscectomy model of OA and expressed in hypertrophic
and calcified zones of chick embryonic growth plates. Unstimu-
lated chondrocytes constitutively expressed F-spondin, which de-
creased following exposure to IL-1 (10 ng/ml). In contrast, PGE2
(1-10 uM), significant increased F-spondin expression from 4-
48h following stimulation. This effect could be mimicked by the
cAMP analog, dibutyryl cAMP. Addition of F-spondin increased
PGE2 production in chondrocytes, which could be inhibited by
avb3 integrin blocking antibody LM609. Addition of growth fac-
tors FGF-basic, FGF-18 and TGF-b, enhanced the expression
